Prulifloxacin: in vitro (HERG current) and in vivo (conscious dog) assessment of cardiac risk

Author： Lacroix P.   Crumb W.J.   Durando L.   Ciottoli G.B.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.477, Iss.1, 2003-09, pp. : 69-72

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiac electrophysiological effects of falipamil in the conscious dog: comparison with alinidine

By Boucher M.   Chassaing C.   Chapuy E.  

European Journal of Pharmacology, Vol. 306, Iss. 1, 1996-06 ,pp. : 93-98

Elsevier

Access to resources Recommend Favorite

Cardiac electrophysiological effects of propafenone and its 5-hydroxylated metabolite in the conscious dog

By Boucher M.   Chassaing C.   Hamel J.-D.   Poirier J.-M.  

European Journal of Pharmacology, Vol. 315, Iss. 2, 1996-11 ,pp. : 171-177

Elsevier

Access to resources Recommend Favorite

The hERG Channel and Risk of Drug-Acquired Cardiac Arrhythmia: An Overview

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 13, 2008-09 ,pp. : 1102-1112

Bentham Science Publishers

Access to resources Recommend Favorite

hERG (KCNH2 or Kv11.1) K+ Channels: Screening for Cardiac Arrhythmia Risk

By  

Current Drug Metabolism, Vol. 9, Iss. 9, 2008-11 ,pp. : 965-970

Bentham Science Publishers

Access to resources Recommend Favorite

Prulifloxacin

By Susan J. Keam   Caroline M. Perry  

Drugs, Vol. 64, Iss. 19, 2004-01 ,pp. : 2221-2234

Adis International

Access to resources Recommend Favorite